AI and robotics voice infrastructure project Silencio announces that its stablecoin campaign has begun, allowing users to participate and earn rewards every hour.
According to TechFlow, as per the official announcement, the AI and robotics voice infrastructure project Silencio has announced the launch of its stablecoin campaign. Users who contribute to the campaign can earn a $2 reward per hour (UTC+8), and if the AI recordings are of high quality and pass review, they can receive an incentive of $10 per hour (UTC+8).
Previously, Silencio announced that it had collected over 720,000 recordings and more than 8,100 hours of authentic spoken data within a few weeks, which will be used for AI and robotics-related voice training. By sharing audio data, users can earn Silencio's official token $SLC. The new $SLC utility will be developed in collaboration with @FoundationSLC to increase the hourly rate for $SLC holders.
Silencio is a voice infrastructure project built on peaq, which collects real voice data to provide training data for AI models and robots, enabling robots to better hear and understand voice information.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Zcash co-founder releases ZIP proposal to "terminate ZCG funding channel and instead support NSM"

Citadel warns: Tech stock sell-off is just the first warning sign, AI trading offers "almost no room for error"
The sell-off in tech stocks reflects rising doubts about AI profitability, with Citadel stating that there is very little margin for error in AI trading. Grayscale noted that demand is parabolic, and capital expenditure presents a two-sided risk.
Daiwa raises Tesla's target price to $390

U.S. judge rejects injunction, Novo Nordisk (NVO.US) loses first round in blocking Eli Lilly (LLY.US) weight-loss drug advertisements
On Monday, a U.S. judge dismissed Novo Nordisk's request to prohibit Eli Lilly from continuing to run advertisements for weight-loss drugs. The Danish pharmaceutical company argued that the ads were false and misleading, in a market with annual sales worth tens of billions of dollars.
